Physician profile
Lance Eric Radbill
NPI 1740244383
$3,909.75
in general payments reported to CMS, 2019-2025
42 companies · $479 in 2025
The $479 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $281 · 2021: $700 · 2022: $577 · 2023: $1,161 · 2024: $254 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,894.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allegis Pharmaceuticals, LLC | $789.50 | 2023 | Urimar-T Caps |
| Abbvie INC. | $653.55 | 2019-2025 | |
| Astellas Pharma US INC | $439.69 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $297.46 | 2023-2025 | Gemtesa, Myfembree |
| Amgen INC. | $142.15 | 2019-2022 | |
| Hologic Sales and Service, LLC | $123.72 | 2019-2025 | Novasure, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Urovant Sciences INC | $123.06 | 2021-2022 | |
| Myovant Sciences INC. | $120.81 | 2021-2022 | |
| Pfizer INC. | $113.04 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $101.04 | 2022-2025 | |
| Scynexis, INC. | $76.54 | 2022 | |
| Channel Medsystems, INC. | $73.49 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.92 | 2020-2024 | Xifaxan |
| Exeltis, USA INC. | $70.75 | 2020-2024 | Slynd |
| Shield Therapeutics INC | $69.84 | 2023-2025 | Accrufer |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Radbill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.